ACADIAN ASSET MANAGEMENT LLC - EIGER BIOPHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$71
-51.0%
238,034
+15.5%
0.00%
-100.0%
Q2 2023$145
-42.7%
206,113
-27.0%
0.00%0.0%
Q1 2023$253
-56.2%
282,471
-42.4%
0.00%
-66.7%
Q4 2022$578
-99.5%
490,488
+3575.4%
0.00%
Q2 2021$114,000
+165.1%
13,345
+360.5%
0.00%
Q4 2019$43,000
-65.0%
2,898
-75.0%
0.00%
-100.0%
Q2 2019$123,000
-44.3%
11,602
-26.7%
0.00%0.0%
Q1 2019$221,000
-58.7%
15,838
-69.9%
0.00%
-66.7%
Q4 2018$535,000
-49.0%
52,642
-39.8%
0.00%
-25.0%
Q3 2018$1,049,000
+52.7%
87,427
+55.4%
0.00%
+33.3%
Q2 2018$687,000
+236.8%
56,266
+171.2%
0.00%
+200.0%
Q1 2018$204,00020,7480.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$8,532,0005.82%
P.A.W. CAPITAL CORP 400,000$4,916,0004.34%
Telemetry Investments, L.L.C. 128,848$1,584,0002.68%
Trellus Management Company, LLC 206,404$2,537,0002.09%
KNOTT DAVID M 295,035$3,626,0001.64%
683 Capital Management, LLC 2,683,600$32,982,0001.56%
INTERWEST VENTURE MANAGEMENT CO 764,918$9,401,0001.17%
TOWERVIEW LLC 130,000$1,598,0001.14%
Vivo Capital, LLC 1,791,257$22,015,0000.98%
Altium Capital Management LP 197,500$2,427,0000.91%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders